---
title: "Ozempic may offer a surprising bonus benefit for brain health"
date: 2025-12-13T13:52:34.000Z
category: Health
externalLink: "https://www.sciencedaily.com/releases/2025/12/251213042249.htm"
image: ""
excerpt: "A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be less likely to develop epilepsy than those taking DPP-4 inhibitors. Semaglutide showed the strongest connection to lowered risk. Researchers caution that the findings show an association, not proof of cause and effect. More rigorous long-term studies are needed toâ€¦"
---